Detalles de la búsqueda
1.
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
J Pathol
; 262(2): 226-239, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964706
2.
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Lancet Oncol
; 25(2): 198-211, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301689
3.
Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials.
World J Surg
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658171
4.
PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer.
Br J Cancer
; 128(2): 245-254, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36352028
5.
RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
Ann Surg Oncol
; 30(2): 792-801, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400886
6.
The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer.
Br J Cancer
; 124(4): 786-796, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33223535
7.
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer.
N Engl J Med
; 378(13): 1177-1188, 2018 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29590544
8.
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study.
BMC Cancer
; 21(1): 354, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794823
9.
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
Lancet Oncol
; 21(12): 1620-1629, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33271092
10.
Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014).
Br J Cancer
; 122(6): 749-758, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932755
11.
Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study.
BMC Cancer
; 20(1): 1165, 2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256671
12.
The Moderating Influence of Moral Disapproval of Pornography on Couples' Sexual and Relationship Satisfaction.
J Sex Marital Ther
; 46(7): 660-682, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32573369
13.
First-line trifluridine/tipiracil plus bevacizumab for unresectable metastatic colorectal cancer: SOLSTICE study design.
Future Oncol
; 16(4): 21-29, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31914811
14.
Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression.
Future Oncol
; 16(28): 2177-2189, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32716216
15.
Beyond Bergmann's rule: Global variability in human body composition is associated with annual average precipitation and annual temperature volatility.
Am J Phys Anthropol
; 170(1): 75-87, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31318051
16.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611518
17.
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.
Br J Cancer
; 119(6): 697-706, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30116024
18.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
Br J Cancer
; 119(11): 1332-1338, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30420616
19.
ASO Visual Abstract: RAS Mutation Status Should not be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.
Ann Surg Oncol
; 30(2): 802-803, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404378
20.
Predicting Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendix Adenocarcinoma.
Dis Colon Rectum
; 61(7): 795-802, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29771808